SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
INCR - Incara Pharmaceuticals Corporation
An SI Board Since July 1999
Posts SubjectMarks Bans
13 0 0
Emcee:  JEB Type:  Unmoderated
Introduction Compact
New name (used to be Intercardia - ITRC). They swapped shares of CPEC for 4.2 Million shares of ITRC stock in a buy-back swap with IPIC. They still own 35% of CPEC for BEXTRA phase III completion in November. They are no longer a subsidiary of Interneuron - IPIC.

The future holds promise for this one.

(As of this date, the symbol is still ITRC, should change within a week to the new symbol of INCR)

Do some DD on this one. It's worth it!
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
13 Jim, I don't know what its worth, but I have been adviced to buy this stocJon-10/26/1999
12 OUCH: go2net.newsalert.comJEB-7/30/1999
11 INCR profile: biz.yahoo.comJEB-7/27/1999
10 True, ...feel free! It helps keep me on my DD. Good trading, JEB JEB-7/25/1999
9 < For my next posts, I was planning to argue with myself...hmmm...I still mJim Bishop-7/24/1999
8 Good bet...you win! I also know someone who has Crohn's and I am monitorJEB-7/24/1999
7 Hate to see you over here talking to just yourself Jeb. I'm perking up on Jim Bishop-7/24/1999
6 It's official INCR is the new symbol. It just started trading today. ThatJEB-7/23/1999
5 INCR news source: quote.yahoo.comJEB-7/23/1999
4 Incara owns a subsidiary (Renaissance Cell Technologies) which is running pre-cJEB-7/22/1999
3 Incara owns a subsidiary (Aeolus Pharmaceuticals) which has synthesized small mJEB-7/22/1999
2 An IND (Investigational New Drug) was approved for OP2000 by the FDA and will bJEB-7/22/1999
1 The stock swap effectively reduces the outstanding shares to 3.1 Million. AlsoJEB-7/22/1999
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News